Central Nervous System Stimulants
"Central Nervous System Stimulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
Descriptor ID |
D000697
|
MeSH Number(s) |
D27.505.696.282 D27.505.954.427.220
|
Concept/Terms |
Analeptics- Analeptics
- Analeptic Drugs
- Drugs, Analeptic
- Analeptic Agents
- Agents, Analeptic
|
Below are MeSH descriptors whose meaning is more general than "Central Nervous System Stimulants".
Below are MeSH descriptors whose meaning is more specific than "Central Nervous System Stimulants".
This graph shows the total number of publications written about "Central Nervous System Stimulants" by people in this website by year, and whether "Central Nervous System Stimulants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 0 | 1 | 1 |
1996 | 4 | 1 | 5 |
1997 | 2 | 0 | 2 |
1998 | 2 | 0 | 2 |
1999 | 2 | 0 | 2 |
2000 | 4 | 0 | 4 |
2001 | 4 | 1 | 5 |
2002 | 2 | 1 | 3 |
2003 | 4 | 1 | 5 |
2004 | 3 | 0 | 3 |
2005 | 1 | 0 | 1 |
2006 | 5 | 2 | 7 |
2007 | 7 | 4 | 11 |
2008 | 8 | 3 | 11 |
2009 | 4 | 0 | 4 |
2010 | 6 | 1 | 7 |
2011 | 9 | 1 | 10 |
2012 | 7 | 1 | 8 |
2013 | 6 | 4 | 10 |
2014 | 4 | 1 | 5 |
2015 | 6 | 3 | 9 |
2016 | 9 | 1 | 10 |
2017 | 8 | 0 | 8 |
2018 | 9 | 3 | 12 |
2019 | 9 | 0 | 9 |
2020 | 2 | 1 | 3 |
2021 | 3 | 0 | 3 |
2022 | 2 | 0 | 2 |
2023 | 1 | 0 | 1 |
2024 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Central Nervous System Stimulants" by people in Profiles.
-
Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduct J. 2024 Nov 29; 21(1):214.
-
Impact of childhood adversity on acute subjective effects of stimulant and opioid drugs: Evidence from placebo-controlled studies in healthy volunteers. J Psychopharmacol. 2024 Nov; 38(11):986-997.
-
The 3,4-methylenedioxymethamphetamine enhances early visual processing for salient socio-emotional stimuli. Eur J Neurosci. 2024 Jun; 59(12):3224-3235.
-
Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine. Neuropsychopharmacology. 2024 Jun; 49(7):1120-1128.
-
Variation in HIV Transmission Behaviors Among People Who Use Drugs in Rural US Communities. JAMA Netw Open. 2023 08 01; 6(8):e2330225.
-
Factors predicting incarceration history and incidence among Black and Latino men who have sex with men (MSM) residing in a major urban center. PLoS One. 2022; 17(3):e0265034.
-
Stimulant use interventions may strengthen 'Getting to Zero' HIV elimination initiatives in Illinois: Insights from a modeling study. Int J Drug Policy. 2022 05; 103:103628.
-
Acute drug effects differentially predict desire to take dextroamphetamine again for work and recreation. Psychopharmacology (Berl). 2021 Oct; 238(10):2815-2826.
-
Neural correlates of inhibitory control are associated with stimulant-like effects of alcohol. Neuropsychopharmacology. 2021 07; 46(8):1442-1450.
-
Subjective responses predict d-amphetamine choice in healthy volunteers. Pharmacol Biochem Behav. 2021 05; 204:173158.